menu
    • menu

    Company profile for Jacobio Pharma

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jacobio is committed to providing more products and solutions to people’s health. Our mission is to provide compelling innovations for creating a pipeline of life-changing medicines. Our vision is to become a global leader recognized for our impact in drug R&D together with our partners. The company’s R&D centers are located in Beijing and Massachusetts, with a platform and expertise in developing allosteric inhibitors aga...
    Jacobio is committed to providing more products and solutions to people’s health. Our mission is to provide compelling innovations for creating a pipeline of life-changing medicines. Our vision is to become a global leader recognized for our impact in drug R&D together with our partners. The company’s R&D centers are located in Beijing and Massachusetts, with a platform and expertise in developing allosteric inhibitors against protein tyrosine phosphatase, KRAS and transcriptional factors. The company is financed by several top-tier investors, including QiMing, Lilly Asia Ventures, Hillhouse and BioEngine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jacobio PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Building F2, No.88 of Kechuang 6th St., Daxing District, Beijing 101111
    Telephone
    Telephone
    +86 010-56315466
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://en.jacobiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/jacobiopharma/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jacobio Enter Global Exclusive License Agreement with AstraZeneca
    Jacobio Enter Global Exclusive License Agreement with AstraZeneca

    21 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jacobio-pharma-enters-global-exclusive-license-agreement-with-astrazeneca-for-pan-kras-inhibitor-jab-23e73-302647567.html

    PR NEWSWIRE
    21 Dec 2025
    Share Share
    Jacobio Hits 71% ORR, Paves Way for First SHP-2 NSCLC Therapy
    Jacobio Hits 71% ORR, Paves Way for First SHP-2 NSCLC Therapy

    04 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/jacobio-combo-delivers-71-orr-sets-stage-for-first-shp-2based-nsclc-therapy-18447

    INDPHARMAPOST
    04 Dec 2025
    Share Share
    Jacobio Present Pre-clinical data Pan-KRAS Inhibitor Data
    Jacobio Present Pre-clinical data Pan-KRAS Inhibitor Data

    24 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jacobio-presents-pre-clinical-data-of-pan-kras-inhibitor-jab-23e73-at-aacr-nci-eortc-international-conference-302592811.html

    PR NEWSWIRE
    24 Oct 2025
    Share Share
    Jacobio Pharma & Oceanpine Capital Partner For Oncology Pipeline
    Jacobio Pharma & Oceanpine Capital Partner For Oncology Pipeline

    15 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jacobio-pharma-announces-strategic-partnership-with-oceanpine-capital-to-focus-on-core-oncology-pipeline-302584801.html

    PR NEWSWIRE
    15 Oct 2025
    Share Share
    Jacobio Pharma Announces 2025 Interim Results
    Jacobio Pharma Announces 2025 Interim Results

    30 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jacobio-pharma-announces-2025-interim-results-302542189.html

    PR NEWSWIRE
    30 Aug 2025
    Share Share
    Jacobio's IND Accept for Ph I/II Trial of BET Inhibitor JAB-8263
    Jacobio's IND Accept for Ph I/II Trial of BET Inhibitor JAB-8263

    02 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jacobios-ind-for-phase-iii-clinical-trial-of-bet-inhibitor-jab-8263-in-autoimmune-diseases-has-been-accepted-302497083.html

    PR NEWSWIRE
    02 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search